Added to YB: 2023-07-12
Pitch date: 2023-07-12
AVRO [bullish]
AVROBIO, Inc.
+2.94%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of June 20, 2024, AVROBIO, Inc. was acquired by Tectonic Therapeutic, Inc., in a reverse merger transaction.
Market Cap
$62.9M
Pitch Price
$16.32
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.58
P/E
2.08
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
AVROBIO: Another Broken Biotech, Clinical Assets Potentially Worth Something
A summary for this pitch has not been created yet.
Read full article (1 min)